In vivo efficacy of the CD40 agonist antibody CP-870,893 against a broad range of tumor types: Impact of tumor CD40 expression, dendritic cells, and chemotherapy.

被引：0

作者：

Gladue, R. P. ^{[1
]}

Cole, S. H. ^{[1
]}

Donovan, C. ^{[1
]}

Paradis, T. ^{[1
]}

Alpert, R. ^{[1
]}

Natoli, E. ^{[1
]}

Bedian, V. ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Groton, CT USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：103S / 103S

页数：1

共 50 条

[41] The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation
Sum, Eva
Rapp, Moritz
Duerr, Harald
Mazumdar, Alekhya
Romero, Pedro J.
Trumpfheller, Christine
Umana, Pablo
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
[42] Morphological characteristics and co-stimulatory molecule (CD80, CD86, CD40) expression in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma
Jia, Jianjun
Wang, Zineng
Li, Xiaomao
Wang, Zhixin
Wang, Xiaoyu
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 160 (02) : 223 - 227
[43] Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation
Hermans, IF
Ritchie, DS
Daish, A
Yang, JP
Kehry, MR
Ronchese, F
JOURNAL OF IMMUNOLOGY, 1999, 163 (01): : 77 - 81
[44] Regulation of tumor necrosis factor-α expression by CD40 ligation in BV-2 microglial cells
Jana, M
Dasgupta, S
Liu, XJ
Pahan, K
JOURNAL OF NEUROCHEMISTRY, 2002, 80 (01) : 197 - 206
[45] Runx proteins mediate protective immunity against Leishmania donovani infection by promoting CD40 expression on dendritic cells
Akhtar, Naushad
Mishra, Manish
Yadav, Vinod
Yadav, Manisha
Gujar, Ravindra
Lal, Sunaina
Kumar, Raj
Khatri, Neeraj
Sen, Pradip
PLOS PATHOGENS, 2020, 16 (12)
[46] Enhanced CD40 and ICOSL expression on dendritic cells surface improve anti-tumor immune responses; effectiveness of mRNA/chitosan nanoparticles
Daneshmandi, Saeed
Pourfathollah, Ali Akbar
Forouzandeh-Moghaddam, Mehdi
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2018, 40 (05) : 375 - 386
[47] The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy
Frankish, Jamie
Mukherjee, Debayan
Romano, Erminia
Billian-Frey, Katharina
Schroder, Matthias
Heinonen, Karl
Merz, Christian
Redondo Mueller, Mauricio
Gieffers, Christian
Hill, Oliver
Thiemann, Meinolf
Honeychurch, Jamie
Illidge, Tim
Sykora, Jaromir
FRONTIERS IN IMMUNOLOGY, 2023, 14
[48] T cell inflammation in the tumor microenvironment after agonist CD40 antibody: Clinical and translational results of a neoadjuvant clinical trial.
Byrne, Katelyn T.
Betts, Courtney B.
Mick, Rosemarie
Sivagnanam, Shamilene
Bajor, David L.
Laheru, Daniel A.
Chiorean, E. Gabriela
O'Hara, Mark H.
Liudahl, Shannon M.
Newcomb, Craig
Alanio, Cecile
Ferreira, Ana P.
Park, Byung S.
Ohtani, Takuya
Huffman, Austin P.
Vayrynen, Sara A.
Costa, Andressa Dias
Kaiser, Judith C.
Lacroix, Andreanne M.
Redlinger, Colleen
Stern, Martin
Nowak, Jonathan A.
Wherry, E. John
Cheever, Martin A.
Wolpin, Brian M.
Furth, Emma E.
Jaffee, Elizabeth M.
Coussens, Lisa M.
Vonderheide, Robert H.
CANCER RESEARCH, 2021, 81 (13)
[49] Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice
Aghevlian, Sadaf
Wu, Bo
Raie, Marina Nura
Tumbale, Spencer K.
Kare, Aris J.
Seo, Jai W.
Ferrara, Katherine W.
NUCLEAR MEDICINE AND BIOLOGY, 2021, 98-99 : 8 - 17
[50] A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells
Oba, Takaaki
Hoki, Toshifumi
Yamauchi, Takayoshi
Keler, Tibor
Marsh, Henry C.
Cao, Xuefang
Ito, Fumito
JOURNAL OF IMMUNOLOGY, 2020, 205 (07): : 1867 - +

← 1 2 3 4 5 →